Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

April 2016

Pacific Rubiales investors never saw the knife coming. Sure, they knew there were tough times ahead. Shares in the company had been at $6+ in mid-2015, and as high…
In Vancouver’s Gastown, if you tossed a rock hard in any general direction, you’re going to hit a tech worker in the side of his horn-rimmed head. Or a…
Update: We’ve been officially launched for two weeks now. Here’s what traffic is doing: That’s satisfying. We’ve signed three sponsors in that time: Equitas Resources: $0.05 UP to $0.065 Veritas…
The best investment I’ve made in the last year was perhaps the dumbest, least informed purchase I’ve made in my life. Golden Secret. Golden Secret Ventures (GGS.V) was at…
  Editor’s note: This is Mark Dankel’s debut in what I hope will be a long run of pieces aimed at sticking a shiv in the shivworthy. Let’s just…
I’ve had my eye on a not-yet-public outfit from Brazil called Ydreams for the past year or so now. They’ve been a long time coming. Ydreams is in the…
Cannabis research play Veritas Pharmaceuticals (VRT.C) announced news after yesterday’s close, as predicted here at Equity.Guru, and the news was most definitely good. If you’re in the cancer research…
Busy day prowling the halls of Vancouver’s brokers today, jamming CEO meetings from 8am through to a few minutes ago. Caught up with the crews from Health Space (HS.C)*,…
Had a long and detailed discussion last night with the very busy CEO of Veritas Pharma (VRT.C)*, Dr. Lui Franciosi, and came away pretty impressed with the man and his…
Great morning if you’ve been doing your due diligence through Equity Guru – some of our favourites have been jumping today by 20% or more. Nano One Materials* (NNO.V)…